BRIANNE SHERGILL
@Exome Asset Management Llc
Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.
Assets under management
The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LLYEli Lilly & Co
| 6.31% | $18.511M 20,894 shares@ $885.94 avg price | Increased 115.41% |
ASNDAscendis Pharma A S
| 4.47% | $13.094M 87,698 shares@ $149.31 avg price | Increased 338.49% |
BBIOBridgebio Pharma Inc
| 3.66% | $10.744M 422,000 shares@ $25.46 avg price | Increased 434.81% |
GPCRStructure Therapeutics Inc
| 3.6% | $10.548M 240,330 shares@ $43.9 avg price | New Position |
TGTXTg Therapeutics Inc
| 3.31% | $9.713M 415,254 shares@ $23.4 avg price | Increased 65.05% |
ALGNAlign Technology Inc
| 3.24% | $9.512M 37,400 shares@ $254.32 avg price | New Position |
CIThe Cigna Group
| 2.88% | $8.453M 24,400 shares@ $346.44 avg price | Increased 100% |
GILDGilead Sciences Inc
| 2.86% | $8.384M 100,000 shares@ $83.84 avg price | New Position |
GERNGeron Corp
| 2.8% | $8.219M 1.81M shares@ $4.54 avg price | New Position |
BNTXBiontech Se
| 2.8% | $8.207M 69,104 shares@ $118.77 avg price | New Position |